Methods of Determining Plasma and Tissue Binding of Drugs

SummaryThe available techniques for the investigation of drug binding to plasma and tissues protein are reviewed and the advantages and disadvantages of the various techniques stated. A comparison of different plasma protein binding techniques is made which shows that the size of the unbound fraction of drug may be influenced by the method used. Protein binding may be assayed by methods including equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration, binding to albumin microspheres and circular dichroism. Tissue binding techniques can involve testing binding to isolated organs, tissue slices, homogenates and isolated subcellular particles. Details of the available methods to compute pharmacokinetic constants are given. Stereoselective binding has been investigated for a limited number of drugs and the difference in the binding of 2 enantiomers is usually modest. The measurement of the binding constants is often required to characterise the drug-protein interaction. Mathematical and graphical methods to compute the pharmacokinetic parameters are discussed. The implications of binding on the volume of distribution and clearance of drugs are examined.

[1]  P. K. Smith,et al.  The interaction of barbiturates with serum albumin and its possible relation to their disposition and pharmacological actions. , 1954, The Journal of pharmacology and experimental therapeutics.

[2]  B. Whiting,et al.  Factors affecting drug binding in plasma of elderly patients. , 1976, British journal of clinical pharmacology.

[3]  R. Braithwaite,et al.  Techniques for plasma protein binding of demethylchlorimipramine , 1979, Clinical pharmacology and therapeutics.

[4]  H A Feldman,et al.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. , 1972, Analytical biochemistry.

[5]  J. Kampmann,et al.  Quantitative and qualitative binding characteristics of disopyramide in serum from patients with decreased renal and hepatic function. , 1987, British journal of clinical pharmacology.

[6]  D. Sandnes,et al.  Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis. , 1983, British journal of clinical pharmacology.

[7]  R. P. Maickel,et al.  Subcellular distribution of weak acids and bases in adrenal medulla. , 1982, General pharmacology.

[8]  J. Perrin,et al.  Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements. , 1979, Biochimica et biophysica acta.

[9]  C. Cerletti,et al.  SUBCELLULAR DISTRIBUTION OF ETORPHINE IN RAT BRAIN AND EVIDENCE FOR in vivo STEREOSPECIFIC BINDING , 1978, British journal of pharmacology.

[10]  M. Anttila,et al.  Effect of food, food constituents and fluid volume on the bioavailability of sotalol. , 2009, Acta pharmacologica et toxicologica.

[11]  T. Trnovec,et al.  Different binding of propranolol enantiomers to human alpha 1-acid glycoprotein. , 1989, Biochemical pharmacology.

[12]  P. McNamara,et al.  Tissue binding of drugs. , 1977, Journal of pharmaceutical sciences.

[13]  R. Andersson,et al.  Biochemical and morphological characterization of subcellular fractions isolated from rabbit colon muscle. , 2009, Acta pharmacologica et toxicologica.

[14]  C. Post,et al.  Studies on the pharmacokinetic function of the lung with special reference to lidocaine. , 2009, Acta pharmacologica et toxicologica.

[15]  W. Dreyer,et al.  Measurement of protein-binding phenomena by gel filtration. , 1962, Biochimica et biophysica acta.

[16]  B. Fichtl,et al.  Binding of drugs to tissues. , 1983, Drug metabolism reviews.

[17]  B. Rosen,et al.  A multichamber equilibrium dialysis apparatus. , 1972, Analytical biochemistry.

[18]  C. Kasper [26] Isolation and properties of the nuclear envelope , 1974 .

[19]  C. Kunin Binding of antibiotics to tissue homogenates. , 1970, The Journal of infectious diseases.

[20]  R. Vestal,et al.  Uptake of propranolol by the lung and its displacement by other drugs: involvement of the alveolar macrophage. , 1980, Pharmacology.

[21]  A. Pruitt,et al.  Furosemide binding to human albumin and plasma of nephrotic children , 1975, Clinical pharmacology and therapeutics.

[22]  C. Chignell Optical Studies of Drug-Protein Complexes , 1969 .

[23]  W. Jusko,et al.  Determination and prediction of tissue binding of prednisolone in the rabbit. , 1984, Journal of pharmaceutical sciences.

[24]  J F Zaroslinski,et al.  Effect of temperature on the binding of salicylate by human serum albumin. , 1974, Biochemical pharmacology.

[25]  I. Sjöholm,et al.  Improved stability of proteins immobilized in microparticles prepared by a modified emulsion polymerization technique. , 1978, Journal of pharmaceutical sciences.

[26]  M. Carrai,et al.  The effect of ageing on plasma albumin and plasma protein binding of diazepam, salicylic acid and digitoxin in healthy subjects and patients with renal impairment. , 1992, British journal of clinical pharmacology.

[27]  I. Gonda,et al.  LUNG ACCUMULATION OF SOME β‐ADRENOCEPTOR ANTAGONISTS , 1978 .

[28]  W. Lindup Methods for the measurement of drug binding to plasma proteins , 1980 .

[29]  A. Rane,et al.  Clonazepam serum protein binding during development , 1984, Clinical pharmacology and therapeutics.

[30]  B. Sébille,et al.  The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance , 1984 .

[31]  T. Ludden,et al.  Binding of organic compounds to rat liver and lung. , 1976, Drug Metabolism And Disposition.

[32]  V. Ringberger,et al.  Protein binding of salicylate in uremic and normal plasma , 1976, Clinical pharmacology and therapeutics.

[33]  I. Sjöholm,et al.  Direct and indirect determination of binding constants of drug-protein complexes with microparticles. , 1978, Journal of pharmaceutical sciences.

[34]  M. Carrai,et al.  Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs. , 1986, Therapeutic drug monitoring.

[35]  I. M. Klotz,et al.  Properties of graphical representations of multiple classes of binding sites. , 1971, Biochemistry.

[36]  M. Bickel,et al.  Characterization of drug distribution and binding competition by two-chamber and multi-chamber distribution dialysis. , 1987, Journal of pharmaceutical sciences.

[37]  G. Levy,et al.  Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium , 1975, Clinical pharmacology and therapeutics.

[38]  F. Belpaire,et al.  Binding of drugs in serum, blood cells and tissues of rabbits with experimental acute renal failure. , 1981, Pharmacology.

[39]  J. Lima,et al.  Stereoselective binding of disopyramide to human plasma protein. , 1984, Life sciences.

[40]  L. Schanker,et al.  PHYSIOLOGICAL DISPOSITION OF GUANETHIDINE IN THE RAT AND ITS UPTAKE BY HEART SLICES. , 1965, International journal of neuropharmacology.

[41]  H. Mehendale,et al.  Absence of metabolism of morphine during accumulation by isolated perfused rabbit lung. , 1979, Drug metabolism and disposition: the biological fate of chemicals.

[42]  A. Guarino,et al.  Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver. , 1980, Toxicology and applied pharmacology.

[43]  M. Carrai,et al.  Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[44]  A. Rane,et al.  Plasma protein binding of diphenylhydantoin in man; Interaction with other drugs and the effect of temperature and plasma dilution , 1970, Clinical pharmacology and therapeutics.

[45]  L. Notarianni Plasma Protein Binding of Drugs in Pregnancy and in Neonates , 1990, Clinical pharmacokinetics.

[46]  I. Sjöholm,et al.  Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles. , 1979, Molecular pharmacology.

[47]  S Oie,et al.  Effect of altered plasma protein binding on apparent volume of distribution. , 1979, Journal of pharmaceutical sciences.

[48]  T. Orton,et al.  Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs. , 1973, The Journal of pharmacology and experimental therapeutics.

[49]  D. Ofori-Adjei,et al.  Protein binding of chloroquine enantiomers and desethylchloroquine. , 1986, British journal of clinical pharmacology.

[50]  Bernard,et al.  Advances in Drug Research , 1964 .

[51]  Y. Sugiyama,et al.  Comparison between in‐vivo and in‐vitro tissue‐to‐plasma unbound concentration ratios (Kp,f) of quinidine in rats , 1984, The Journal of pharmacy and pharmacology.

[52]  G. Rolinson,et al.  The binding of antibiotics to serum proteins. , 1965, British journal of pharmacology and chemotherapy.

[53]  U. Wollert,et al.  Interaction of benzodiazepine derivatives with bovine serum albumin-I Gel filtration studies. , 1976, Biochemical pharmacology.

[54]  G. Wilkinson,et al.  The disposition of propranolol. IV. A dominant role for tissue uptake in the dose-dependent extraction of propranolol by the perfused rat liver. , 1973, The Journal of pharmacology and experimental therapeutics.

[55]  M. Bickel,et al.  Intracellular binding and metabolism of imipramine and imipramine-N-oxide. , 1971, Chemico-biological interactions.

[56]  S. Colowick,et al.  Binding of diffusible molecules by macromolecules: rapid measurement by rate of dialysis. , 1969, The Journal of biological chemistry.

[57]  E. Perucca,et al.  Plasma Protein Binding of Drugs in Pregnancy , 1982, Clinical pharmacokinetics.

[58]  S. Dutta,et al.  THE UPTAKE AND SUBCELLULAR DISTRIBUTION OF RADIO‐LABELLED METABOLITES OF DIGITOXIN IN THE GUINEA‐PIG ISOLATED PERFUSED HEART , 1976, British journal of pharmacology.

[59]  J. Leysen,et al.  Specific in vivo binding of neuroleptic drugs in rat brain. , 1977, Biochemical pharmacology.

[60]  H. Rosenthal A graphic method for the determination and presentation of binding parameters in a complex system. , 1967, Analytical biochemistry.

[61]  R. Minchin,et al.  Comparative uptake of quinine and quinidine in rat lung , 1981, The Journal of pharmacy and pharmacology.

[62]  R. Branch,et al.  The disposition of propranolol. VII. The effects of saturable hepatic tissue uptake on drug clearance by the perfused rat liver. , 1973, Drug metabolism and disposition: the biological fate of chemicals.

[63]  V. Mlynárik,et al.  Interaction of pirprofen enantiomers with human serum albumin. , 1991, Chirality.

[64]  C. Cotman,et al.  Analytical differential centrifugation: an analysis of the sedimentation properties of synaptosomes, mitochondria and lysosomes from rat brain homogenates. , 1970, Archives of biochemistry and biophysics.

[65]  C. Longhini,et al.  Subcellular distribution of deslanatoside C, ouabain and digitoxin in the heart and liver of conscious guinea pigs. , 1977, Biochemical pharmacology.

[66]  C. Chignell Optical studies of drug-protein complexes. IV. The interaction of warfarin and dicoumarol with human serum albumin. , 1970, Molecular pharmacology.

[67]  P. Morselli,et al.  Clinical Pharmacokinetics in Newborns and Infants , 1980 .

[68]  S. Dutta,et al.  Subcellular distribution of digoxin-H3 in isolated guinea-pig and rat hearts. , 1968, The Journal of pharmacology and experimental therapeutics.

[69]  K. Piafsky Disease-induced Changes in the Plasma Binding of Basic Drugs , 1980, Clinical pharmacokinetics.

[70]  A. Wilson,et al.  Uptake, metabolism and efflux of methadone in "single pass" isolated perfused rabbit lungs. , 1976, The Journal of pharmacology and experimental therapeutics.

[71]  B. Brodie,et al.  Physiological disposition and fate of chlorpromazine and a method for its estimation in biological material. , 1956, The Journal of pharmacology and experimental therapeutics.

[72]  S. Månér,et al.  Preparation and characterization of subcellular fractions from the head kidney of the Northern pike (Esox lucius), with particular emphasis on xenobiotic-metabolizing enzymes. , 1985, Biochemical pharmacology.

[73]  P. A. Shore,et al.  Distribution of clozapine in the rat: localization in lung. , 1978, The Journal of pharmacology and experimental therapeutics.

[74]  T. Blanck,et al.  β-Adrenergic receptor ligand binding by rabbit lung☆ , 1979 .

[75]  T. Bjornsson,et al.  Lidocaine plasma protein binding , 1980, Clinical pharmacology and therapeutics.

[76]  T. Trnovec,et al.  Kinetics of gentamicin accumulation in subcellular structures of the mouse kidney , 1982, The Journal of pharmacy and pharmacology.

[77]  G. Dallner,et al.  Isolation of rough and smooth microsomes from rat liver by means of a commerically available centrifuge. , 1969, Analytical biochemistry.

[78]  I. Sjöholm,et al.  Studies on the binding of benzodiazepines to human serum albumin by circular dichroism measurements. , 1976, Biochemical pharmacology.

[79]  H. Nau,et al.  Microscale ultrafiltration technique for determining free drug in 50-microL serum samples. , 1984, Clinical Chemistry.

[80]  G R Wilkinson,et al.  Clearance approaches in pharmacology. , 1987, Pharmacological reviews.

[81]  S. Garattini,et al.  Basic and Therapeutic Aspects of Perinatal Pharmacology , 1976 .

[82]  N. Anderson,et al.  Analytical techniques for cell fractions. 8. Analytical differential centrifugation in angle-head rotors. , 1968, Analytical Biochemistry.

[83]  S. Dromgoole The effect of haemodialysis on the binding capacity of albumin. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[84]  F. Andreasen,et al.  Protein binding of drugs in plasma from patients with acute renal failure. , 2009, Acta pharmacologica et toxicologica.

[85]  Klotz Im,et al.  The Binding of Organic Ions by Proteins1 , 1946 .

[86]  R. Wise The Clinical Relevance of Protein Binding and Tissue Concentrations in Antimicrobial Therapy , 1986, Clinical pharmacokinetics.

[87]  A. Rane,et al.  Subcellular Distribution of Styrene Oxide in Rat Liver , 1984, Toxicologic pathology.

[88]  L. Stern,et al.  Sephadex G-25 quantitative estimation of free bilirubin potential in jaundiced newborn infants sera: a guide to the prevention of kernicterus. , 1972, The Journal of laboratory and clinical medicine.

[89]  G. Wilkinson Plasma and tissue binding considerations in drug disposition. , 1983, Drug metabolism reviews.

[90]  T. Blaschke Protein Binding and Kinetics of Drugs in Liver Diseases , 1977, Clinical pharmacokinetics.

[91]  H. Mehendale,et al.  Uptake and metabolism of chlorpromazine by rat and rabbit lungs. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[92]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[93]  W. E. Lindup,et al.  Interaction of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, an inhibitor of plasma protein binding in uraemia, with human albumin. , 1990, Biochemical pharmacology.

[94]  D. Shand,et al.  The Disposition of Propranolol , 1972 .

[95]  M. Rowland Protein Binding and Drug Clearance , 1984, Clinical pharmacokinetics.

[96]  U. Wollert,et al.  Interaction of benzodiazepine derivatives with bovine serum albumin-II. Circular dichroism studies. , 1976, Biochemical pharmacology.

[97]  L. Storstein Protein Binding of Cardiac Glycosides in Disease States , 1977, Clinical pharmacokinetics.

[98]  F. L. Crane,et al.  The purification and biochemical characterization of bovine liver nuclear membranes. , 1972, The Journal of biological chemistry.

[99]  I. Sipes,et al.  Liver slices in dynamic organ culture. II. An in vitro cellular technique for the study of integrated drug metabolism using human tissue. , 1991, Xenobiotica; the fate of foreign compounds in biological systems.

[100]  A. Junod ACCUMULATION OF 14C-IMIPRAMINE IN ISOLATED PERFUSED RAT LUNGS , 1972 .

[101]  B. K. MARTIN,et al.  Potential Effect of the Plasma Proteins on Drug Distribution , 1965, Nature.

[102]  R. Gugler,et al.  Drug Protein Binding and the Nephrotic Syndrome , 1976, Clinical pharmacokinetics.

[103]  W J Jusko,et al.  Plasma and tissue protein binding of drugs in pharmacokinetics. , 1976, Drug metabolism reviews.

[104]  A. Amar‐Costesec,et al.  Analytical study of microsomes and isolated subcellular membranes from rat liver VIII. Subfractionation of preparations enriched with plasma membranes, outer mitochondrial membranes, or Golgi complex membranes , 1981, The Journal of cell biology.

[105]  J. T. Yang,et al.  Comparison of circular dichrometers: normal and difference circular dichroism measurements. , 1972, Analytical biochemistry.

[106]  J. Crooks,et al.  Altered Plasma Protein Binding of Drugs in Thyroid Disease , 1981, Clinical pharmacokinetics.

[107]  H. Mehendale,et al.  Chlorphentermine uptake by isolated perfused rabbit lung. , 1980, Toxicology and applied pharmacology.

[108]  T. Orton,et al.  Accumulation of amines in the isolated perfused rabbit lung. , 1974, The Journal of pharmacology and experimental therapeutics.

[109]  I. Sjöholm,et al.  Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate. , 1980, Molecular pharmacology.

[110]  G. Powis,et al.  Human and dog, but not rat, isolated hepatocytes have decreased foreign compound-metabolizing activity compared to liver slices. , 1989, Drug metabolism and disposition: the biological fate of chemicals.

[111]  W. E. Lindup Plasma protein binding of drugs: some basic and clinical aspects , 1987 .

[112]  M. Reidenberg The Binding of Drugs to Plasma Proteins from Patients with Poor Renal Function , 1976, Clinical pharmacokinetics.

[113]  R. Anderson,et al.  Hepatic uptake of propranolol. , 1978, The Journal of pharmacology and experimental therapeutics.

[114]  B. Fichtl,et al.  Tissue Binding versus Plasma Binding of Drugs: General Principles and Pharmacokinetic Consequences , 1991 .

[115]  P. Rehberg A Centrifugation Method of Ultraflltration Using Cellophane Tubes , 1943 .

[116]  B. Veering,et al.  The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein. , 1990, British journal of clinical pharmacology.

[117]  M. Barry,et al.  Severity of cirrhosis and the relationship of α1‐acid glycoprotein concentration to plasma protein binding of lidocaine , 1990 .

[118]  J. Mackichan Pharmacokinetic Consequences of Drug Displacement from Blood and Tissue Proteins , 1984, Clinical pharmacokinetics.

[119]  W. Rummel,et al.  Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates. , 1970, The Journal of pharmacology and experimental therapeutics.

[120]  I. Sjöholm,et al.  Independent binding of ligands to human serum albumin. , 1977, The Journal of biological chemistry.

[121]  P. Laduron Tissue fractionation in neurobiochemistry: an analytical tool or a source of artifacts. , 1977, International review of neurobiology.

[122]  M. Eichelbaum,et al.  Stereoselective protein binding of verapamil enantiomers. , 1988, Biochemical pharmacology.

[123]  M. J. Smith,et al.  The relation between circulating and tissue concentrations of salicylate in the mouse in vivo , 1970, The Journal of pharmacy and pharmacology.

[124]  D. Wallach,et al.  Isolation of plasma membrane vesicles from animal cells. , 1977, Methods in cell biology.

[125]  T. Trnovec,et al.  Interaction of propafenone enantiomers with human alpha 1-acid glycoprotein. , 1991, Chirality.

[126]  M. Eadie,et al.  Plasma protein binding of diphenylhydantoin Effects of sex hormones, renal and hepatic disease , 1974, Clinical pharmacology and therapeutics.

[127]  Y. Sawada,et al.  Effect of sulfadimethoxine on thiopental distribution and elimination in rats. , 1981, Journal of pharmaceutical sciences.

[128]  I. Kopin,et al.  Subcellular distribution of Δ9-tetrahydrocannabinol in rat brain , 1974 .

[129]  S. Paul,et al.  Subcellular distribution of high affinity [3H]imipramine binding and [3H]serotonin uptake in rat brain. , 1983, European journal of pharmacology.

[130]  C. Cerletti,et al.  3H-reserpine persistently bound "in vivo" to rat brain subcellular components: limited removal by peanut oil extraction. , 1974, Life sciences.

[131]  L. Manara,et al.  DRUG DISTRIBUTION IN THE BRAIN , 1978 .

[132]  D. Perrier,et al.  The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum. , 1981, Clinical chemistry.

[133]  A. Rane,et al.  Nuclear epoxide hydrolase in the human fetal and adult liver. , 1984, Pharmacology.

[134]  M. Reidenberg Effect of disease states on plasma protein binding of drugs. , 1974, The Medical clinics of North America.

[135]  H. Paulus A rapid and sensitive method for measuring the binding of radioactive ligands to proteins. , 1969, Analytical biochemistry.

[136]  J. Pritchard,et al.  Studies on the uptake and binding of propranolol by rat tissues. , 1977, The Journal of pharmacology and experimental therapeutics.

[137]  C T Dollery,et al.  CONCENTRATION OF (±)‐PROPRANOLOL IN ISOLATED, PERFUSED LUNGS OF RAT , 1976, British journal of pharmacology.

[138]  W. Jusko,et al.  Theophylline tissue partitioning and volume of distribution in normal and dietary-induced obese rats. , 1987, Biopharmaceutics & drug disposition.

[139]  W. Jusko,et al.  Distribution volume related to body weight and protein binding. , 1982, Journal of pharmaceutical sciences.

[140]  A. Schibeci,et al.  The binding of arsenazo III to cell components. , 1980, Biochimica et biophysica acta.

[141]  J. McElnay,et al.  Drug interactions involving the displacement of drugs from plasma protein and tissue binding sites. , 1982, Pharmacology & therapeutics.

[142]  R. Verbeeck,et al.  Plasma Protein Binding of Drugs in the Elderly , 1987, Clinical pharmacokinetics.

[143]  R. Branch,et al.  A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol. , 1976, British Journal of Clinical Pharmacology.

[144]  Y. Sugiyama,et al.  Effect of quinidine on the tissue binding of digoxin in guinea‐pigs , 1986, The Journal of pharmacy and pharmacology.

[145]  E. Rolleri,et al.  Use of serum albumin microspheres as a reversible adsorbent for studying protein-small molecule interactions. , 1973, Biochimica et biophysica acta.

[146]  John T. Wilson,et al.  Clinical Pharmacokinetics in Infants and Children , 1976, Clinical pharmacokinetics.

[147]  J. Zaroslinski,et al.  Protein binding methodology: comparison of equilibrium dialysis and frontal analysis chromatography in the study of salicylate binding. , 1972, Analytical biochemistry.

[148]  C. Eap,et al.  Binding of d‐methadone, 1‐methadone, and dl‐methadone to proteins in plasma of healthy volunteers: Role of the variants of α1‐acid glycoprotein , 1990, Clinical pharmacology and therapeutics.

[149]  A. Holmgren,et al.  Tissue distrubution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. , 1978, Biochemistry.

[150]  Lindup We,et al.  Excretion of the uraemic metabolite 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human urine. , 1990 .

[151]  P. Morselli,et al.  Studies on plasma protein binding of carbamazepine. , 1974, Pharmacological research communications.

[152]  S. Jacobsen,et al.  Binding of quinidine in serum and heart from normal and anuric rats, and the significance for distribution. , 1979, Biochemical pharmacology.

[153]  J. Konopa,et al.  In vitro binding of metabolically activated [14C]-ledakrin, or 1-nitro-9-14C-(3'-dimethylamino-N-propylamino) acridine, a new antitumor and DNA cross-linking agent, to macromolecules of subcellular fractions isolated from rat liver and HeLa cells. , 1979, Biochemical pharmacology.

[154]  R. Kuntzman,et al.  Importance of tissue and plasma binding in determining the retention of norchlorcyclizine and norcyclizine in man, dog and rat. , 1967, The Journal of pharmacology and experimental therapeutics.

[155]  C. Danpure,et al.  The uptake and subcellular distribution of gold in rat liver cells after in vivo administration of sodium aurothiomalate. , 1977, Biochemical pharmacology.

[156]  G. Placidi,et al.  Subcellular distribution of pinazepam and its metabolite N-desmethyldiazepam in rat liver. , 1984, General pharmacology.

[157]  I. Sjöholm,et al.  Correlation between arginyl residue modification and benzodiazepine binding to human serum albumin. , 1977, Journal of Biological Chemistry.

[158]  F. Andreasen,et al.  The binding of thiopental to serum proteins determined by ultrafiltration and equilibrium dialysis. , 2009, Acta pharmacologica et toxicologica.

[159]  D. Drayer,et al.  Alteration of Drug-Protein Binding in Renal Disease , 1984, Clinical pharmacokinetics.

[160]  H. Nau,et al.  Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels. , 1984, British journal of clinical pharmacology.

[161]  J. Tillement,et al.  Diseases and Drug Protein Binding , 1978, Clinical pharmacokinetics.

[162]  G. Powis,et al.  A high-performance liquid chromatography assay for measuring integrated biphenyl metabolism by intact cells: its use with rat liver and human liver and kidney. , 1987, Analytical biochemistry.

[163]  G. Levy,et al.  Serum protein binding of drugs and bilirubin in newborn infants and their mothers , 1980, Clinical pharmacology and therapeutics.

[164]  K. Netter Progress in drug metabolism , 1985 .

[165]  M. Contin,et al.  Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. , 1984, British journal of clinical pharmacology.

[166]  H. Kurz,et al.  Binding of Drugs to Human Skin: Influencing Factors and the Role of Tissue Lipids , 1988, The Journal of pharmacy and pharmacology.

[167]  Malcolm Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[168]  A. Danon,et al.  Binding of imipramine to plasma proteins: Effect of hyperlipoproteinemia , 1979, Clinical pharmacology and therapeutics.

[169]  P. McNamara,et al.  Stereoselective binding of propranolol in the elderly. , 1989, British journal of clinical pharmacology.

[170]  F. Sjöqvist,et al.  Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. , 1978, The New England journal of medicine.

[171]  R. Kay,et al.  Rapid isolation of nuclear envelopes from rat liver. , 1977, Methods in cell biology.

[172]  M D Hill,et al.  The Significance of Plasma Protein Binding on the Fetal/Maternal Distribution of Drugs at Steady-State , 1988, Clinical pharmacokinetics.